Nexus Pharmaceuticals opened a $100 million manufacturing facility in July of 2021 in Pleasant Prairie, Wis. Increasing the nation's domestic supply of life-saving medicines, the 84,000-sf structure will produce specialty and generic injectable drugs, including vaccines for COVID-19 and other infectious diseases. The three-story building features an advanced isolator system and multiple lyophilization machines to ensure maximum product protection and sterility. Integrated Project Services was the architect for the sustainably designed facility, which leverages highly efficient equipment, infrastructure, and processes to achieve superior energy performance. Turner Construction began work on the project in August of 2019. The manufacturing center represents the first phase of a $250 million campus that will be built out over the next ten years.